🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested
The objective of the present trial is: * to determine the dose limiting to...
Status
Withdrawn
Location
Gustave Roussy Institute,
Start Date
2012-06
Trial ID
NCT01764009
Treatments Being Tested
RATIONALE: Providing information that is tailored to answer patients' quest...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-04
Trial ID
NCT00750009
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
1998-03
Trial ID
NCT00003192
Treatments Being Tested
The trial is designed as a multi-center, open label Phase 2 trial that inve...
Status
Completed
Location
3203; Antwerp University Hospital; Department of Medical Oncology
Start Date
2011-07
Trial ID
NCT01417936
Treatments Being Tested
This Phase I/II trial studies the safety and effectiveness of lenalidomide ...
Status
Completed
Location
University of Chicago
Start Date
2013-10-17
Trial ID
NCT01838434
Treatments Being Tested
This is a multicenter, open-label, evaluator-blinded, investigator-initiate...
Status
Completed
Location
Beijing Tian tan Hospital
Start Date
2024-03-11
Trial ID
NCT06064734
Treatments Being Tested